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Proteolytic selection for protein folding using filamentous
bacteriophages
Peter Kristensen and Greg Winter
Background: Filamentous bacteriophages have been used for the selection
of folded peptide and protein ‘ligands’ by binding the phage to ‘receptor’-
coated solid phase. Here, using proteolysis, we have developed a technique
for the selection of folded and stable proteins that is independent of their
binding activities.
Results: When a 21-residue peptide comprising a protease cleavage site was
introduced into the flexible linker between the second and third domains of the
minor coat protein p3 of filamentous bacteriophage, the phages could be cleaved
by trypsin and were rendered non-infective. By contrast, phages displaying mutant
barnases at this site were resistant to proteolysis, but were cleaved and their
infectivity was destroyed as the temperature was raised. By mixing phages
bearing two barnase mutants of differing stability, and adding protease at a
temperature at which one mutant was resistant and the other was sensitive, we
were able to enrich by 1.6 × 104-fold for phages bearing the more stable barnase.
Conclusions: The approach provides a means for the selection of folded and
stable proteins, and may be applicable to the selection of de novo proteins.
Introduction
Attempts have been made to design proteins that are more
stable than native proteins [1–3] and also folded de novo
proteins [1,4]. This has posed significant challenges. An
alternative approach is the use of screening or selection
technologies. Enzymes with improved stability have been
isolated by screening repertoires of mutants at higher tem-
peratures [2] and de novo ‘proteins’ by their ability to
survive degrading enzymes in bacteria [5–7].
Although mass screening is powerful, the use of selection
technologies allow the screening of even greater numbers.
In particular, the use of filamentous bacteriophage has
allowed the isolation of synthetic folded human antibodies
from repertoires of > 1010 members built by the assembly
of different structural elements [8–10]. After assembly, the
antibody genes are cloned into filamentous bacteriophage
by fusion to the bacteriophage coat protein p3 such that
each phage encapsidates a set of antibody genes and dis-
plays the encoded antibody fragment on its surface. Phages
are selected from the repertoire by their binding to solid-
phase antigen. As the antibody needs to be folded to bind
antigen, selection for binding also selects for folding. This
principle has also been used for the selection of folded
peptides, for which binding is mediated by a discontinuous
epitope [11–14].
The binding activities of a protein may be unknown, how-
ever, or the ligand (such as a substrate or product analog for
binding to enzyme) may be unavailable, requiring a means
of selection that is independent of the binding properties of
the folded protein. Proteolysis has already been used as a
means of screening for protein folding; unfolded proteins
are readily digested by proteases whereas folded proteins
are often resistant, cleavage requiring the polypeptide chain
to bind and adapt to the specific stereochemistry of the pro-
tease active site and therefore be flexible, accessible and
capable of local unfolding [15,16]). Here, we sought to use
proteolysis as a means of selection; because filamentous
bacteriophage are reported to be resistant to proteolysis
(allowing their use as ‘substrate’ phage [17]), we devised a
means of selection for protease-resistant proteins displayed
on phage.
The phage p3 protein has three domains (D1, D2 and D3);
D1 binds to the tolA receptor (required for penetration of
the phage DNA), D2 binds to the F-pilus, and D3 anchors
the protein to the phage [18]. Peptides and proteins can be
inserted at the domain boundaries without abolishing
infectivity [19,20], but the presence of all the domains is
essential for phage infectivity [21]. Proteolytic cleavage of
a protein inserted between the domains should therefore
lead to a loss of phage infectivity. Here, we constructed
suitable phage vectors and have demonstrated the principle
of proteolytic selection for folding.
Results
Phage stability
Phage was incubated under a range of denaturing con-
ditions in vitro and then restored to native conditions
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immediately before infection of bacteria. The incubation
of phage in 10 M urea or extremes of pH (as low as pH 2;
and as high as pH 12) and temperature (as high as 60°C)
did not lead to a major loss of infectivity (Table 1). This
indicates that the phage is either resistant to denaturing
conditions or that if it does unfold it is able to refold
rapidly. With guanidine hydrochloride (GdnHCl), how-
ever, a fivefold loss in phage infectivity was observed
above 5 M and a further fivefold loss at 8 M (Table 1).
Phage was then incubated under native conditions with a
range of proteases (trypsin, Factor Xa, IgA protease, Asp–
N, chymotrypsin, Arg–C, Glu–C, thrombin, thermolysin
and subtilisin) with different specificities. There was no
loss in infectivity except for subtilisin, which has been
reported to cleave the p3 protein [22]. If phage was incu-
bated under denaturing conditions in the presence of pro-
teases such as trypsin in 3.5 M urea (or > 47°C), infectivity
was lost. This indicates that under denaturing conditions
the unfolding of the phage coat proteins is sufficient to
make sites available for proteolysis.
A sequence (PAGLSEGSTIEGRGAHE) comprising sev-
eral proteolytic sites was inserted in the flexible glycine-rich
region between the D2 and D3 domains of the phage p3.
Incubation of the phage (fd-K108) under native conditions
with trypsin, thermolysin or subtilisin resulted in an almost
complete loss of infectivity (from 107 to < 10 TU/ml) and
incubation with Glu–C and chymotrypsin resulted in a
major loss (from 107 to 104 TU/ml). This indicates that
these proteases cleave the new linker. Incubation with
Factor Xa, Arg–C or thrombin, however, did not lead to a
loss in infectivity, despite the presence of potential cleav-
age sites for these enzymes. Presumably, the presence of
the D2 and D3 domains may block access or cleavage for
these enzymes.
Protease-cleavable helper phage and phagemid
Fusion of proteins to p3 should lead to a multivalent
display of the protein on the phage. But if the protein is
fused to p3 encoded by a phagemid (such as pHEN1
[23]), and the bacteria harbouring the phagemid is rescued
with a helper phage (such as VCSM13), the fusion protein
has to compete for incorporation into the phage with the
helper p3. This leads to so-called ‘monomeric’ phage, in
which usually less than one copy of the fusion protein is
attached to each phage particle [24].
The use of monomeric phage might be expected to be
more sensitive to proteolysis because only a single copy of
fusion protein need be cleaved for the phage to be ren-
dered non-infectious and interactions between multimers
of fusion protein would be avoided. This would also
require the construction of a protease-cleavable helper
phage, however. We therefore introduced the protease-
cleavage sequence between the D2 and D3 domains to
generate the helper phage KM13.
KM13 was shown to rescue the phagemid pHEN1. Fur-
thermore, trypsin was shown to cleave a major fraction
(~50%) of p3 of the rescued phage, as shown by Western
blot and detected with an anti-D3 mAb (Figure 1). Phage
infectivity was hardly altered by the cleavage; it therefore
appears that only a fraction of the p3 needs to be intact to
mediate bacterial infection.
KM13 was also shown to rescue a pHEN1 phagemid
encoding a single-chain antibody fragment [25]. Here,
cleavage by trypsin resulted in a 50-fold loss in phage
infectivity (data not shown), consistent with indications
that only a small fraction of the phage express fusion
protein when rescued with helper phage [24,26]. 
We also constructed a protease-cleavable phagemid. The
phagemid could be rescued with KM13 or VCSM13. As
expected, infectivity of this phagemid rescued with KM13
(but not VCSM13) was destroyed by trypsin (data not
shown). Later experiments showed that this phagemid
vector was prone to deletions in the D2–D3 linker; by
changing the codon usage in the linker regions on either
side of the protease-cleavable site, and shortening the
length of these linker regions, we created a more stable
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Table 1
The stability of fd-DOG in different denaturing conditions.
Condition Infectivity (TU/ml × 1010)
Urea (60°C, 90 min)
Control 0.56
2 M 0.64
4 M 0.32
6 M 0.32
8 M 0.80
10 M 0.68
GdnHCl (37°C, 90 min)
Control 0.72
2 M 0.60
4 M 0.70
5 M 0.16
6 M 0.13
7 M 0.16
8 M 0.03
pH (37°C, 30 min)
Control 1.5
pH 2.2 0.46
pH 4.0 1.3
pH 7.4 1.5
pH 10 1.4
pH 12 0.40
Temperature (30 min)
Control 9.7
22°C 8.3
37°C 9.6
60°C 12.0
The infectivity (TU/ml × 1010) was measured (see the Materials and
methods section) and has an estimated error of about ± 6%.
vector (pK1, Figure 2). In a second vector (pK2), the
sequence of the polylinker was arranged in order to place
D3 out of frame to render re-ligations within the polylinker
non-infectious (Figure 2).
Selection for folding
Barnase
Barnase is a small RNAse of 110 amino acids whose
folding has been extensively studied (for review see [27]).
Barnase contains multiple sites for trypsin cleavage,
although the folded protein is resistant to cleavage (data
not shown). Phage with barnase cloned between D2 and
D3 should therefore be resistant to protease cleavage and
capable of selection.
Because barnase is toxic to Escherichia coli, we cloned
mutant A (His102→Ala), which is catalytically inactive but
stable [28,29], into the phagemid pK2. We also cloned
mutant B (His102→Ala, Leu14→Ala) with lower stability;
Leu14 is buried in the hydrophobic core and its mutation
creates a large cavity in the core affecting the packing of
different structural elements [30]. The phages (rescued
with KM13) were shown to bind to the inhibitor barstar by
ELISA, and therefore display the mutant barnases in a
folded form (Figure 3).
The phages were then incubated with trypsin at a range of
temperatures (Figure 4). After incubation at 10°C, there
was a decrease in phage infectivity of 5–10-fold for both
mutants, suggesting that only a small fraction of the phages
display the fusion protein. There was no further loss in
infectivity on cleavage until 30°C (for mutant B) or 37°C
(for mutant A). In both cases, the major transition was at
least 10°C below that expected for the reversible thermal
unfolding of the mutants.
We then mixed phages A and B in different ratios and
incubated the mixture at 20°C with trypsin, a temperature
at which both mutants are stable to cleavage, or at 37°C, at
which only phage A is stable. After ‘proteolytic selection’
the phages were plated and analysed by PCR followed by
restriction digest, which distinguishes the mutants. As
shown in Table 2, after a single round of selection at 37°C,
mutant A was enriched by a factor of 1.6 × 104, and after
two rounds by 1.3 × 106. No enrichment could be detected
at 20°C.
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Figure 1
Cleavage of phages with protease sites. Phages were prepared by
rescue with KM13 (pHEN1, A + B), or with VCSM13 (pK1, C + D).
Uncleaved (A + C) or cleaved with trypsin (B + D). 5 µl, 2.5 µl and 1 µl
phages were loaded as indicated. Molecular weight markers are in kDa.
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The phagemid vectors pK1 and pK2. These vectors contain a protease-cleavable sequence between D2 and D3 of the phage p3 protein. In pK1,
D2 + D3 are in frame; in pK2, D3 is out of frame.
Villin
The 35 amino acid subdomain of the headpiece domain of
the f-actin-bundling protein villin [31] is much smaller than
barnase, but is stable to temperature and to proteolysis; fur-
thermore, its stability does not rely on disulfide bonds or
binding ligands [32]. The villin subdomain, which contains
several potential trypsin cleavage sites, was cloned between
the D2 and D3 domains of the phage, and incubated with
trypsin at different temperatures (Figure 4). The profile for
loss of infectivity was not as sharp as with barnase, with the
major transition below 35°C, considerably below the ther-
mal unfolding of villin (70°C; [31,32]). The phage display-
ing villin were mixed with pK1 and incubated with trypsin.
After a single round of proteolytic selection, the fusion
phage were enriched 8.7 × 103-fold (Table 3).
Discussion
Our results show that the infectivity of the phage is rela-
tively resistant to temperature, pH, urea and GdnHCl, and
to several proteases, but if a flexible linker comprising a pro-
tease-cleavage site is inserted between domains D2 and D3
of the phage coat protein p3, the phage becomes sensitive
to cleavage. By contrast, if the protease-cleavage sites com-
prise a folded protein domain, such as barnase or villin, the
phage is resistant to cleavage. This allows proteolytic selec-
tion for protein folding with enrichment factors of > 104-fold
for a single round of selection. Selection was evident for
barnase, an average sized [33] domain of 110 amino acids,
and for villin, a small domain of 35 amino acids.
Although the approach seems general, there are several lim-
itations. The phage has to be capable of resisting the diges-
tion conditions; in future it may be possible to select phages
with improved stability to act as carriers for proteins to be
selected. The protein of interest has to be exported through
the bacterial membrane into the periplasm and also has to
contain a cleavage site for the chosen protease (thus requir-
ing the use of different proteases or a cocktail of proteases).
Furthermore, the protein has to fall apart on nicking. In
some cases the cleaved portions are expected to remain non-
covalently attached, but are likely to have a lower stability
than the native structure [34–36] and should be amenable
to being teased apart with denaturants (see below).
Discrimination between structures of different stabilities
can be accomplished by increasing the stringency of prote-
olytic selection. Thus, with increases in temperature, both
barnase and villin became susceptible to cleavage, reflecting
protein unfolding. The main impact of protease cleavage,
however, was at a temperature lower than the unfolding
transition as measured by CD [37]. This may reflect the fact
that the unfolding transition is a fully reversible process,
whereas cleavage by proteases (of unfolded structure) is a
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Figure 3
Binding of phage–barnase to barstar. Phages displaying different
fusion proteins are incubated with biotinylated barstar captured on a
streptavidin-coated plate and are detected by ELISA.
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Figure 4
Temperature denaturation of phage fusion proteins. Phagemids were
rescued with KM13. Infectivity is shown after incubation and cleavage
with trypsin at given temperatures. Fusion is with the villin subdomain,
barnase mutant A, barnase mutant B and chloramphenicol-resistant
pHEN1.
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kinetic and irreversible process, pulling over the equilib-
rium from folded to unfolded (and cleaved) structure. This
is consistent with the CD unfolding transition seen for villin
[32] for which at temperatures as low as 35°C there is evi-
dence of unfolding; this is the same point at which villin
starts to become susceptible to protease attack.
We anticipate several areas for the application of prote-
olytic selection for protein folding because it should allow
much larger numbers of proteins to be processed than with
screening. Proteolytic selection may, for example, allow
the isolation of mutant proteins with improved stability [1];
for example, from combinatorial libraries of mutants in
which residues at several sites are varied simultaneously
[38,39] or from random mutants or by recombination [2,40].
Proteolytic selection may also facilitate the isolation of pro-
teins de novo [5–7,41]; although such proteins may well
retain elements of secondary structure, they often lack the
stable tertiary interactions characteristic of the folding of
native proteins, suggesting the presence of molten glob-
ules [3]. It may be possible to improve packing and stable
tertiary interactions by using several rounds of mutation
and increasingly stringent proteolytic selection, much like
the affinity maturation of antibodies.
We also anticipate other uses for proteolytic selection. For
phage display repertoires many of the phage do not
display the protein [24], but are infective by virtue of the
p3 contributed by the helper phage. As these phages con-
tribute to the background of non-specific binding to
antigen-coated solid phase, the use of protease-cleavable
helper phage should destroy their contribution to the back-
ground and thereby improve selection efficiencies. This
requires the fusion of the protein to intact p3, however,
either at the N terminus or between domain boundaries.
Furthermore, it may be possible to use proteolytic selec-
tion for the identification of interacting protein elements.
Thus, if two such elements linked by a protease-cleavable
linker were cloned between the D2 and D3 domains for
display on phage, the only infectious phages after proteoly-
sis should be those in which the D2 and D3 domains are
held together by non-covalent interactions between the
interacting protein elements. This should provide an alter-
native to other phage selection strategies for molecular
interactions based on the association of the domains of
p3 [42–44].
Materials and methods
Materials
All restriction enzymes and T4 ligase were obtained from New England
Biolabs. Taq DNA polymerase were obtained from HT Biotechnology.
Pfu DNA polymerase was obtained from Stratagene. Ultrapure dNTP
was from Pharmacia. Proteases and the protease inhibitor Pefabloc were
from Boehringer Mannheim, except chymotrypsin and trypsin TPCK-
treated, which were obtained from Sigma. All other chemicals were
obtained from Sigma.
Phage preparation
Escherichia coli TG1 [45] was used for cloning and propagation of
phage. TG1 harbouring fd-DOG [46] or derivatives was grown over-
night in 2 × TY containing 15 µg/ml tetracycline. Phagemids were
rescued using KM13 or VCSM13 as described [25]. Phage particles
were prepared by two PEG precipitations [47].
Vector construction
The phage vector fd-DOG [46] was used as the parent vector for the
construction of the protease cleavable fd-K108. Unique restriction sites
(SfiI and KpnI) were introduced into the glycine-rich spacer region
between D2 and D3 using the Sculptor in vitro mutagenesis system
(Amersham) and the oligonucleotide pklinker (Table 4). Further restriction
sites (ApaI and SalI) and sequence encoding a protease-cleavage site
were cloned between the SfiI and KpnI sites using the oligonucleotides
polyXafor and polyXaback to create the vector fd-K108.
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Table 2
Selection of barnase mutants.
Round Ratio of phage A : phage B
1:1* 1:102 1:104 1:106 1:108
Round 1 Phage A 16 (14†) 24 20 0 nd
Phage B 8 (10†) 0 4 24 nd
Enrichment – – 1.6 × 104 – nd
Round 2 Phage A nd nd nd 24 0
Phage B nd nd nd 12 36
Enrichment nd nd nd 1.3 × 106 –
Mixtures of barnase mutants (A + B) in ratios from 1:1 to 1:10–8 were
selected by proteolysis at 37°C; 24 (in round 1) or 36 (in round 2)
phage clones were analysed and the numbers of each mutant were
noted. *Selection at 20°C, at which temperature both mutants are
expected to be stable. †Before selection. nd, not detected.
Table 3
Selection of villin.
pK1 : villin–phage
Sample 1:1 1:10–2 1:10–4 1:10–6
pK1 0 (16*) 0 7 24
Villin 24 (8*) 24 17 0
Enrichment – – 8.7 × 103 –
Mixtures of villin–phage and pK1 rescued with KM13 in ratios from 1:1
to 1:10–6 were selected by proteolysis at 10°C; 24 phage clones were
analysed and the number of each was noted. *Before selection.
The protease-cleavable helper phage KM13 was prepared from
fd-K108 by transplanting into the helper phage VCSM13 a BamHI–ClaI
fragment generated by PCR and primers fdPCRBack and LIBSEQfor.
A protease-cleavable phagemid vector was derived from fd-K108 as
above except using pCANTAB 3 (Pharmacia). A FLAG-tag was intro-
duced at the N terminus of D1 by cloning a NotI–SfiI fragment gener-
ated by PCR and primers Flagprimer and LSPAback. To circumvent
deletions resulting from repeated sequence in the D2–D3 linker, the
codon usage of the polylinker region was changed in two steps: using
a BamHI–SfiI fragment generated by PCR and primers RECGLYfor
and LIBSEQfor, screening recombinants by PCR and the primers
LSPAfor and LSPAback; and using a KpnI–ClaI fragment generated by
PCR and the primers RECGLYback and LIBSEQback, screening
recombinants using LSPAfor and LSPAback. The entire p3 gene was
sequenced using PCR cycle sequencing with fluorescent dideoxy
chain terminators (Applied Biosystem) according to [48]. The ‘out of
frame’ vector pK2 (Figure 2) was derived from pK1 by site-directed
mutagenesis using the oligo delCKpn and the Sculptor Amersham kit.
Cloning of barnase and villin
The vectors encoding the single barnase mutants, His102→Ala and
Leu14→Ala [28,49], were used as templates for PCR amplification
with primers Barnasefor and BarnaseH102Aback and Pfu polymerase.
The PCR products (encoding the single mutant His102→Ala and the
double mutant His102→Ala, Leu14→Ala) were digested using the
restriction enzymes SfiI and KpnI, and ligated into vector pK2 to give
the phagemids pK2BA and pK2BB, respectively, and the barnase
genes sequenced using PCR cycle sequencing.
The 35 amino acid thermostable fragment of the headpiece of the
f-actin-binding protein villin [32] was amplified from chicken bursa
cDNA using PCR primers villinfor and villinback with Pfu polymerase.
The PCR products were cloned as above to give the phagemid pK2V.
Resistance of phages to denaturants, pH and proteases
For resistance to denaturants, 10 M urea in PBS (25 mM NaH2PO4,
125 mM NaCl pH 7.0) or 8 M GdnHCl and 50 mM Tris–HCl pH 7.4,
1 mM CaCl2 (buffer A) was added to 10 µl phage stocks (108–1010 TU)
to give a volume of 1 ml and the conditions specified in Table 1. The
phage were incubated for 1–2 h, then a 100 µl aliquot was added to 1 ml
TG1 (OD600 ~0.5) and serial dilutions were plated on TYE plates with
15 µg/ml tetracycline. For resistance of phages to extremes of
pH (2–12), Tris–glycine or Tris–HCl buffers (0.1 M glycine or 0.1 M Tris
respectively) were added to 10 µl phage stocks, and to neutralise each
100 µl aliquot we added 50 µl 1 M Tris–HCl pH 7.4 before infection. For
resistance to temperature, buffer A was added to 10 µl phage stocks to
give a volume of 1 ml and incubated at a given temperature (20–60°C)
for 1 h. 100 µl aliquots were added to TG1 and plated as above. For
resistance to proteases, 100 mM NaCl, 50 mM Tris–HCl, 1 mM CaCl2
pH 7.4 (Factor Xa 100 ng/ml or trypsin, chymotrypsin, thrombin, ther-
molysin and subtilisin, all 100 µg/ml) or 50 mM Tris–HCl, 1 mM EDTA
pH 7.4 (IgA Protease 10 ng/ml) or 50 mM NH4CO3 pH 8.0 (Arg–C
100 µg/ml, Glu–C 100 µg/ml) or 25 mM NaH2PO4, 125 mM NaCl
pH 7.0 (Asp–N 40 ng/ml) was added to 10 µl phage stocks (fd-DOG
and fd-K108) to give a volume of 100 µl and a final concentration of
protease as indicated. Digestions were incubated for 15 min at room
temperature, samples (100 µl) were then infected into TG1 as above. 
For resistance to proteases in the presence of denaturants, samples
were prepared as above for urea and temperature denaturation. To
90 µl aliquots, 10 µl trypsin (1 mg/ml) was added; after 5 min at room
temperature 4 µl Pefabloc (100 mM) was added and the samples were
infected into TG1 as above.
Western blot
Phages (pHEN1 rescued using KM13 and pK1 rescued using
VCSM13) were subjected to SDS-PAGE [50] before or after cleavage
by trypsin (50 ng/ml). After semi-dry transfer to PVDF membranes the
filter was processed essentially as described [25]. The primary anti-
body, monoclonal anti-gIII (MoBiTec), was added in a 1:5000 dilution
followed by anti-mouse HRP-conjugated antibody (Sigma) in a dilution
of 1:50,000. Finally, the filter was developed using the luminol-based
Chemiluminescence Western Blotting kit (Boehringer Mannheim).
ELISA
Phage displaying barnase mutants were analysed for binding to the
RNase inhibitor barstar as described [47]. 10 pmol biotinylated barstar
(P. Kirkham, D. Neri and G.W., unpublished observations) was mixed
with approximately 1010 phage displaying barnase mutant A, or barnase
mutant B, villin or buffer A. Phage binding barstar was captured on
Streptavidin coated plates (Boehringer Mannheim) and developed using
HRP conjugated anti-M13 antibody (Pharmacia) and 2,2′-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (Sigma). Absorbance readings were
taken at 405 nm.
Temperature denaturation
At each temperature ~1010 phage displaying the barnase mutants or
villin (ampicillin resistant) were mixed with a cleavable control fd-K108
(tetracycline resistant), and a non-cleavable control phagemid, a chloro-
amphenicol-resistant derivative of pHEN1 (P. Wang, unpublished obser-
vations), rescued with KM13 in a total volume of 90 µl of buffer A. After
equilibration for 20–30 min at the temperature indicated, 10 µl trypsin
(5 µg/ml) was added and the incubation continued for 2 min. Trypsin
was neutralised by adding 4 µl 100 mM Pefabloc. Infection and serial
dilution was performed in TG1 as above and aliquots were plated on
TYE plates containing 100 µg/ml ampicillin + 1% glucose, 30 µg/ml
chloroamphenicol + 1% glucose or 15 µg/ml tetracycline.
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Table 4
Primer sequences.
pklinker 5’ GGCACCCTCAGAACGGTACCCCACCCTCAGAGGCCGGCTGGGCCGCCACCCTCAGAG 3’
polyXafor 5’ GGTGGCGGCCCAGCCGGCCTTTCTGAGGGGTCGACTATAGAAGGACGAGGGCCCAGCGAAGGAGGTGGGGTACCCCCTTCTGAGGGTGG 3’
polyXaback 5’ CCACCCTCAGAAGGGGGTACCCCACCTCCTTCGCTGGGCCCTCGTCCTTCTATAGTCGACCCCTCAGAAAGGCCGGCTGGGCCGCCACC 3’
fdPCRBack 5’ GCGATGGTTGTTGTCATTGTCGGC 3’
LIBSEQfor 5’ AAAAGAAACGCAAAGACACCACGG 3’
LIBSEQback 5’ CCTCCTGAGTACGGTGATACACC 3’
LSPAfor 5’ GTAAATTCAGAGACTGCGCTTTCC 3’
LSPAback 5’ ATTTTCGGTCATAGCCCCCTTATTAG 3’
Flagprimer 5’ CAAACGGGCGGCCGCAGACTACAAGGATGACGACGACAAGGAAACTGTTGAAAGTTGTTTAGCAA 3’
RECGLYfor 5’ CCCCTCAGAAAGGCCGGCTGGGCCGCCGCCAGCATTGACAGGAGGTTCAGG 3’
RECGLYback 5’ GAAGGAGGTGGGGTACCCGGTTCCGAGGGTGGTTCCGGTTCCGGTGATTTTG 3’
delCKpn 5’ CCCTCGGAACCGGTACCCCAGCTGCTTCGTGGGCCC 3’
Barnasefor 5’ CTGGCGGCGGCCCAGCCGGCCCTGCACAGGTTATCAACACGTTTGAC 3’
BarnaseH102Aback 5’ CTCGGAACCGGTACCTCTGATTTTTGTAAAGGTCTGATAAGCG 3’
villinfor 5’ GGCGGCCCAGCCGGCCTTTCTCTCTCTGACGAGGACTTCAAGGC 3’
villinback 5’ CCTCGGAACCGGTACCGAAGAGTCCTTTCTCCTTCTTGAGG 3’
Selection experiments
10 µl of serial dilutions of the barnase mutant phage A was mixed with
10 µl of the non-diluted barnase mutant phage B in 70 µl buffer A. After
30 min incubation at 20°C or 37°C, 10 µl trypsin (5 µg/ml) was added.
Following 2 min of digestion, 4 µl Pefabloc (100 mM) was added. The
phage were infected into TG1 as above. A second round of selection
were performed by scraping bacteria in 3 ml 2 × TY, 50 µl inoculated into
50 ml 2 × TY/ampicillin/glutamate and the phagemid rescued and phage
prepared as above. Clones were analysed by PCR using the primers
LSPAfor and LSPAback followed by restriction digestion using DdeI.
Selections between pK2V and pK1 phage particles were performed as
above, except that the selection was performed at 10°C. Clones were
analysed by PCR using the primers LSPAfor and LSPAback.
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